Form 4: Outset Medical Director Patrick Hackett Receives 25,000 Shares of Common Stock

Director Patrick Hackett acquired 25,000 shares of Outset Medical common stock on May 29, 2024, as part of a grant.

Summary

• On May 29, 2024, Patrick Hackett, a director of Outset Medical, Inc., acquired 25,000 shares of common stock.
• The acquisition was a grant, with the price per share being $0.00.
• Following the transaction, Hackett directly owns 42,849 shares of Outset Medical common stock.
• The shares underlying the Restricted Stock Units (RSUs) will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock acquisition by a director. While insider buying can be seen as positive, this is a grant, so it doesn't necessarily reflect a strong bullish sentiment.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future prospects.

Future Outlook

The vesting of the RSUs is tied to the earlier of one year from the grant date or the next Annual Meeting of Stockholders, suggesting a potential future increase in Hackett's holdings.

Industry Context

This transaction is a routine disclosure of insider activity, which is common in publicly traded companies. It provides transparency to investors regarding the holdings and transactions of company insiders.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider activity.
• The acquisition of shares by a director may be viewed positively by shareholders, reflecting confidence in the company.

Next Steps

• The RSUs will vest upon the earlier of one year from the grant date or the date of the next Annual Meeting of Stockholders.

Key Dates